Skip to main content
. 2018 Dec 19;19(12):4122. doi: 10.3390/ijms19124122

Figure 3.

Figure 3

S100A10 immunostaining in matching tissues from a serous ovarian cancer patient at diagnosis (a) and recurrence with chemotherapy-resistant disease (b). S100A10 expression is increased in tumor tissue at relapse with chemotherapy-resistant disease compared to tumor tissue at diagnosis. S100A10 antibody using citrate buffer retrieval (1/1000, BD Biosciences) [16]. Scale bar = 100 µm.